Alembic Pharma issues corporate guarantee for US subsidiary loan

Alembic Pharmaceuticals has issued a corporate guarantee in favor of JPMorgan Chase Bank, N.A., to secure a term loan facility for its wholly-owned US subsidiary, Alembic Pharmaceuticals Inc. (APInc, USA). The guarantee, amounting to USD 22 million, has a tenure of 4.5 years, effective June 17, 2025. Alembic Pharma stated that the issuance of this guarantee is not expected to have any adverse impact on the listed entity, as the total outstanding amount against corporate guarantees issued for credit facility in APInc, USA is NIL. This move underscores Alembic Pharma's commitment to supporting its international operations and expansion.